期刊
ALLERGY AND ASTHMA PROCEEDINGS
卷 28, 期 2, 页码 226-229出版社
OCEAN SIDE PUBLICATIONS INC
DOI: 10.2500/aap.2007.28.2950
关键词
allergic rhinitis; clinical trial; cognitive function; continuous impairment; double blind; intranasal steroid; placebo controlled; seasonal allergic rhinitis; sleep disturbance; somnolence
类别
Patients with symptomatic allergic rhinitis often complain of daytime drowsiness and impairment in their speed of thinking responses. In this study, we compared subjects with allergic rhinitis treated with in tranasal fluticasone propionate or placebo. We measured nasal symptoms, daytime sleepiness, and cognitive performance. Total nasal symptoms (p = 0.002) and nasal congestion (p = 0.003) improved in the intranasal fluticasone propionate group. Concomitantly, daytime sleepiness decreased (p = 0.001) and cognitive performance improved (p = 0.02). The placebo-treated subjects did not show any significant changes. Effective therapy of allergic rhinitis ameliorates the symptoms of daytime sleepiness and decreased cognitive performance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据